Market Cap 3.50B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 4,544,500
Avg Vol 6,994,152
Day's Range N/A - N/A
Shares Out 306.61M
Stochastic %K 90%
Beta 1.32
Analysts Strong Sell
Price Target $17.12

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Stocktradesmoon
Stocktradesmoon Sep. 17 at 1:26 AM
$ABCL KNOWLEDGE is POWER! I have DONE ✅ MY Due Diligence $ABCL • Fastest company ever to deliver an antibody drug against a new viral target – COVID-19. • 14 partner-initiated molecules already in the clinic with downstream economics. • Huge partnered pipeline behind those clinical programs. • Growing internal pipeline with multiple wholly owned programs moving toward the clinic. • ABCL635 just delivered the first major clinical validation of the internal platform. • 83% reduction in hot flash frequency vs 33% placebo. • Strong balance sheet, now strengthened by another $200M. • World-class infrastructure built to discover, develop and manufacture antibodies under one roof. • Years of investment are finally moving from building the platform → producing clinical assets. • And we’re still very early. This is JUST the Beginning!!
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 17 at 1:13 AM
$ABCL AbCellera has just demonstrated that its internal R&D pipeline has genuine delivery capabilities. 🔥 Successful Phase 2 clinical trial for ABCL635 🔥 Significant relief of hot flash symptoms 🔥 Secured $200 million in oversubscribed financing 🔥 Multiple pipeline programs advancing steadily 🔥 Average analyst price target around $30 The key takeaway is the company’s transformation from a pure-play antibody discovery platform into a biotech company with a substantial clinical-stage pipeline. 👀 While still in the early stages, the current momentum is compelling. EXTREMELY Bullish‼️ 🚀
0 · Reply
techinvestoor
techinvestoor Sep. 16 at 11:30 PM
$ABCL Going to $50
1 · Reply
Bastox
Bastox Sep. 16 at 9:57 PM
$ABCL Moondork, As I thought. Since your crap posts are there to see, you can’t defend how wrong you always are. Sad.
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 16 at 9:34 PM
$ABCL New account? Sure buddy 😉😂 BLOCKED!!!! 🤡
0 · Reply
8008track
8008track Sep. 16 at 8:41 PM
$ABCL can’t complain… https://x.com/tyler_bosserman/status/2100322585682772205?s=46&t=19IS2lnKv9JueG0DGj5x7Q
0 · Reply
SultanK
SultanK Sep. 16 at 8:20 PM
$ABCL https://investors.abcellera.com/news/news-releases/2026/AbCellera-Announces-Presentation-of-Phase-2-Data-for-ABCL635-at-the-IMS-World-Congress-on-Menopause-2026/default.aspx
0 · Reply
Bastox
Bastox Sep. 16 at 8:16 PM
$ABCL Poor embarrassed Moondunce. I’m just putting up your own comments. You said no rate hike yesterday, changed your story today and predicted a huge rally after the hike. Oh, and you missed on the 12’s AGAIN! Your posts are on the board for all to see. You try to act like a guru and it’s not working. It’s laughable. Guess the idiot would be you
0 · Reply
Kaykay610
Kaykay610 Sep. 16 at 8:13 PM
$ABCL https://x.com/AbCelleraBio/status/2100315363892502783
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 16 at 8:07 PM
$ABCL Idiot! 🤡 🤡 If you had read my thesis earlier you would know. Trump wanted No Change versus the Market had already priced a .25%! Why do people think raising rates by .25% is an issue lmao Bullish, QE at a massive scale is coming, as Trump would say "Like we have never seen before, the greatest most beautiful money printing machine in history." Good RIDDANCE to You!
0 · Reply
Latest News on ABCL
AbCellera rises 17.0%

2026-08-25T16:06:05.000Z - 22 days ago

AbCellera rises 17.0%


AbCellera rises 10.7%

2026-08-25T14:06:36.000Z - 22 days ago

AbCellera rises 10.7%


AbCellera announces $200M common stock, warrants offering

2026-08-11T20:05:47.000Z - 5 weeks ago

AbCellera announces $200M common stock, warrants offering


AbCellera price target raised to $30 from $12 at Truist

2026-08-11T13:35:37.000Z - 5 weeks ago

AbCellera price target raised to $30 from $12 at Truist


AbCellera Biologics Slides: Corporate presentation

Aug 10, 2026, 8:00 AM EDT - 5 weeks ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Transcript: Study result

Aug 10, 2026, 7:30 AM EDT - 5 weeks ago

AbCellera Biologics Transcript: Study result


AbCellera Biologics Press release: Study result

Aug 10, 2026, 7:30 AM EDT - 5 weeks ago

AbCellera Biologics Press release: Study result


AbCellera Biologics Slides: Study result

Aug 10, 2026, 7:30 AM EDT - 5 weeks ago

AbCellera Biologics Slides: Study result


AbCellera price target raised to $9 from $8 at Stifel

2026-08-06T12:20:50.000Z - 5 weeks ago

AbCellera price target raised to $9 from $8 at Stifel


AbCellera Biologics Earnings Call Transcript: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 6 weeks ago

AbCellera Biologics Earnings Call Transcript: Q2 2026


AbCellera Biologics Slides: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 6 weeks ago

AbCellera Biologics Slides: Q2 2026


AbCellera Biologics Earnings release: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 6 weeks ago

AbCellera Biologics Earnings release: Q2 2026


AbCellera Biologics Quarterly report: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 6 weeks ago

AbCellera Biologics Quarterly report: Q2 2026


AbCellera Reports Q2 2026 Business Results

Aug 5, 2026, 4:05 PM EDT - 6 weeks ago

AbCellera Reports Q2 2026 Business Results


AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 2 months ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 2 months ago

AbCellera apponts Lynn Seely to board of directors

LYEL


AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 2 months ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors


AbCellera Appoints Dr. Victor Sandor to its Board of Directors

Jun 5, 2026, 9:00 AM EDT - 3 months ago

AbCellera Appoints Dr. Victor Sandor to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera Biologics Slides: Corporate presentation

May 1, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 6 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 8 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Transcript: Stifel 2025 Healthcare Conference

Nov 13, 2025, 8:00 AM EST - 10 months ago

AbCellera Biologics Transcript: Stifel 2025 Healthcare Conference


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 10 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 10 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


Stocktradesmoon
Stocktradesmoon Sep. 17 at 1:26 AM
$ABCL KNOWLEDGE is POWER! I have DONE ✅ MY Due Diligence $ABCL • Fastest company ever to deliver an antibody drug against a new viral target – COVID-19. • 14 partner-initiated molecules already in the clinic with downstream economics. • Huge partnered pipeline behind those clinical programs. • Growing internal pipeline with multiple wholly owned programs moving toward the clinic. • ABCL635 just delivered the first major clinical validation of the internal platform. • 83% reduction in hot flash frequency vs 33% placebo. • Strong balance sheet, now strengthened by another $200M. • World-class infrastructure built to discover, develop and manufacture antibodies under one roof. • Years of investment are finally moving from building the platform → producing clinical assets. • And we’re still very early. This is JUST the Beginning!!
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 17 at 1:13 AM
$ABCL AbCellera has just demonstrated that its internal R&D pipeline has genuine delivery capabilities. 🔥 Successful Phase 2 clinical trial for ABCL635 🔥 Significant relief of hot flash symptoms 🔥 Secured $200 million in oversubscribed financing 🔥 Multiple pipeline programs advancing steadily 🔥 Average analyst price target around $30 The key takeaway is the company’s transformation from a pure-play antibody discovery platform into a biotech company with a substantial clinical-stage pipeline. 👀 While still in the early stages, the current momentum is compelling. EXTREMELY Bullish‼️ 🚀
0 · Reply
techinvestoor
techinvestoor Sep. 16 at 11:30 PM
$ABCL Going to $50
1 · Reply
Bastox
Bastox Sep. 16 at 9:57 PM
$ABCL Moondork, As I thought. Since your crap posts are there to see, you can’t defend how wrong you always are. Sad.
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 16 at 9:34 PM
$ABCL New account? Sure buddy 😉😂 BLOCKED!!!! 🤡
0 · Reply
8008track
8008track Sep. 16 at 8:41 PM
$ABCL can’t complain… https://x.com/tyler_bosserman/status/2100322585682772205?s=46&t=19IS2lnKv9JueG0DGj5x7Q
0 · Reply
SultanK
SultanK Sep. 16 at 8:20 PM
$ABCL https://investors.abcellera.com/news/news-releases/2026/AbCellera-Announces-Presentation-of-Phase-2-Data-for-ABCL635-at-the-IMS-World-Congress-on-Menopause-2026/default.aspx
0 · Reply
Bastox
Bastox Sep. 16 at 8:16 PM
$ABCL Poor embarrassed Moondunce. I’m just putting up your own comments. You said no rate hike yesterday, changed your story today and predicted a huge rally after the hike. Oh, and you missed on the 12’s AGAIN! Your posts are on the board for all to see. You try to act like a guru and it’s not working. It’s laughable. Guess the idiot would be you
0 · Reply
Kaykay610
Kaykay610 Sep. 16 at 8:13 PM
$ABCL https://x.com/AbCelleraBio/status/2100315363892502783
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 16 at 8:07 PM
$ABCL Idiot! 🤡 🤡 If you had read my thesis earlier you would know. Trump wanted No Change versus the Market had already priced a .25%! Why do people think raising rates by .25% is an issue lmao Bullish, QE at a massive scale is coming, as Trump would say "Like we have never seen before, the greatest most beautiful money printing machine in history." Good RIDDANCE to You!
0 · Reply
Bastox
Bastox Sep. 16 at 7:55 PM
$ABCL Moonie yesterday: ”🚨With Market already pricing in a RATE HIKE & I suspect we won’t have one! ” Then today Moonlet said he expects a rate hike with a huge rally. A double dose of wrong!
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 16 at 7:43 PM
$ABCL Look 👀 Level II someone just bought 250,000 Shares!!
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 16 at 7:40 PM
$ABCL GET in NOW!!! We about to SQUEEZE!! $12’ssss! Fed raised .25 Market had it priced‼️ Now we can move up SUPER GREEN!!
0 · Reply
Ripvip
Ripvip Sep. 16 at 7:39 PM
$ABCL partners are growing !
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 16 at 7:30 PM
$ABCL We’re GOING SUPER GREEN‼️😉😊 GET in NOW!! Or you will REGRET it!! DON’T MISS OUT!! With the FED RATE HIKE Meeting was at 2. As Expected .25 Hike!! Trust me you want to buy here in the $11.40-50’sss!!! 🚨FED RATE HIKE went up!! BOOM!!! We take OFF!!! BUY all you can RIGHT NOW at a Discount🚨 We ABOUT to SQUEEZE to Mid 12’ssss!!! @DeMampCamp This is GREAT with inflation continuing to rise, a rate hike would certainly be justified! I actually think we could see a market bounce if we receive the hike U.S. equity futures edged higher on Wednesday ahead of a pivotal interest rate decision from the Federal Reserve that could mark the beginning of a new hiking cycle over the next few months. Futures markets were pricing in a quarter-point hike for Wednesday with 92.7% odds, according to the CME FedWatch tool. Odds of an additional quarter-point hike were 41% for the Fed’s October meeting and 27% for the Fed’s December meeting. The current target rate range is 3.5% to 3.75%.
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 16 at 6:43 PM
$ABCL 🤡 🤡
0 · Reply
Bastox
Bastox Sep. 16 at 6:32 PM
$ABCL Hilarious. Moonie said all day yesterday that the Fed wouldn’t raise rates. What a joke
2 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 16 at 3:37 PM
$ABCL GET in NOW!! Or you will REGRET it!! DON’T MISS OUT!! With the FED RATE HIKE Meeting at 2pm EASTERN (1pm Central)!! We are going to go SUPER GREEN!! Trust me you want to buy here in the $11.50’sss!!! As soon as NEWS is out that the FED RATE HIKE went up!! BOOM!!! We take OFF!!! BUY all you can RIGHT NOW at a Discount🚨 We ABOUT to SQUEEZE to Mid 12.60’ssss!!!
0 · Reply
MagicRon_
MagicRon_ Sep. 16 at 3:08 PM
$ABCL PMSL "we found the cure for Cancer" probably gonna drop the news AH today 😆🤡👎
1 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 16 at 3:08 PM
$ABCL “We expect to have another development candidate this year” - Hansen Glad to know we can still expect another molecule behind ABCL688 and ABCL386 this year It’s also interesting to learn that they may stop announcing new developments candidates that make it into IND enabling studies moving forward. They’ll just wait until they are in the clinic. It doesn’t bring that much value announcing earlier. I think they’ll be able to get away with that moving forward because they’ll have enough action in the clinic. A lot to look forward to!! As the pipeline matures, there will be plenty of NEWS and CATALYSTS. We got through the hardest part. ABCL635 was the kickstart to the flywheel. I still believe they will have to let us know about this next one. We’ve all been waiting for it. I was hopeful that it could be done before end of the month but it sems like it’ll be in Q4 at this point.
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 16 at 2:58 PM
$ABCL MORE GREAT NEWS OUT🚨‼️ Looks like we will have global Phase 3 trials in our future. Long and strong! 💪
2 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 16 at 2:39 PM
$ABCL GET IN EVERYBODY‼️ LAST CHANCE you have been TOLD!! WE ARE On BREAK-OUT MODE!! When my Chart Signal’s this I like to call it “BEAST-MODE”!! $ABCL My Chart 📈 SIGNALED!!We About to BREAKOUT 2X RALLY‼️ 💎 Pristine blue diamond (1D) setup... last 2 times led to approx 2X rally. 🔷 💎 printing a Pristine blue diamond on the 1D setup that led to 2X rallies!! 🚨🚨🚨The last two times it signaled a blue diamond the price went 2X!! This is exactly the kind of signal I’m watching! 💥 🤯 😮 I know we’re all about fundamentals here, but damn look at this daily squeeze forming on $ABCL The stock has spent weeks consolidating, momentum has reset and the trend remains intact. If macro cooperates and this squeeze fires to the upside, I believe it could start the next leg higher toward the $14.89-$16.50’ss and then to $20-25 range.
2 · Reply